GBGB1804102.0A
GB201804102D0
(en)
|
2018-03-14 |
2018-03-14 |
Bicycle peptide ligands specific for EphA2
|
TW107144453A
TWI825046B
(en)
|
2017-12-19 |
2018-12-11 |
Bicyclic peptide ligands specific for epha2
|
US16/220,685
US11484602B2
(en)
|
2017-12-19 |
2018-12-14 |
Bicyclic peptide ligands specific for EphA2
|
SG11202005495UA
SG11202005495UA
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2
|
JP2020534623A
JP7293231B2
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for EphA2
|
MX2020006474A
MX2020006474A
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2.
|
HUE18829437A
HUE059126T2
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2
|
ES18829437T
ES2922632T3
(en)
|
2017-12-19 |
2018-12-19 |
EphA2-specific bicyclic peptide ligands
|
PT188294375T
PT3727460T
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2
|
US16/771,186
US11696956B2
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for EphA2
|
LTEPPCT/GB2018/053675T
LT3727460T
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2
|
CN201880089662.7A
CN111787955B
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for EphA2
|
KR1020207019675A
KR20200105839A
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligand specific for EphA2
|
AU2018387418A
AU2018387418B2
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for EphA2
|
KR1020207019676A
KR20200105840A
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligand specific for EphA2
|
AU2018387417A
AU2018387417C9
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for EphA2
|
MX2020006482A
MX2020006482A
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2.
|
JP2020534361A
JP7404241B2
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligand specific for EphA2
|
DK18829437.5T
DK3727460T3
(en)
|
2017-12-19 |
2018-12-19 |
BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2
|
CA3086257A
CA3086257A1
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2
|
CA3085253A
CA3085253A1
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2
|
BR112020012349-8A
BR112020012349A2
(en)
|
2017-12-19 |
2018-12-19 |
epha2-specific bicyclic peptide ligands
|
PCT/GB2018/053675
WO2019122860A1
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2
|
HRP20220871TT
HRP20220871T1
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2
|
PCT/GB2018/053678
WO2019122863A1
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2
|
IL275440A
IL275440B2
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2
|
PL18829437.5T
PL3727460T3
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2
|
SI201830718T
SI3727460T1
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2
|
SG11202005494QA
SG11202005494QA
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2
|
EP18829926.7A
EP3727461A1
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2
|
CN201880089757.9A
CN111741771B
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for EPHA2
|
EP18829437.5A
EP3727460B1
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2
|
BR112020012246-7A
BR112020012246A2
(en)
|
2017-12-19 |
2018-12-19 |
epha2-specific bicyclic peptide ligands
|
EP22161978.6A
EP4053145B1
(en)
|
2017-12-19 |
2018-12-19 |
Bicyclic peptide ligands specific for epha2
|
PH12020550929A
PH12020550929A1
(en)
|
2017-12-19 |
2020-06-17 |
Bicyclic peptide ligands specific for epha2
|
IL275437A
IL275437A
(en)
|
2017-12-19 |
2020-06-17 |
Bicyclic peptide ligands specific for epha2
|
SA520412268A
SA520412268B1
(en)
|
2017-12-19 |
2020-06-18 |
Bicyclic Peptide Ligands Specific for EPHA2
|
US17/934,896
US11833211B2
(en)
|
2017-12-19 |
2022-09-23 |
Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2
|
US18/313,983
US20240000957A1
(en)
|
2017-12-19 |
2023-05-08 |
BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2
|
JP2023093890A
JP7503689B2
(en)
|
2017-12-19 |
2023-06-07 |
Bicyclic peptide ligands specific for EphA2 - Patent Application 20070223333
|
US18/499,739
US20240189436A1
(en)
|
2017-12-19 |
2023-11-01 |
BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2
|
AU2024202618A
AU2024202618A1
(en)
|
2017-12-19 |
2024-04-22 |
Bicyclic peptide ligands specific for EphA2
|